Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market
Holding SLDB?
Track your performance easily

Solid Biosciences (SLDB) Financial Statements

555 Followers

Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently ―. The company's EPS TTM is $-3.292; its P/E ratio is -1.73; Solid Biosciences is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 300.00K----
Gross Profit$ 300.00K----
EBIT$ -24.98M$ -24.21M$ -22.27M$ -20.98M$ -24.63M
EBITDA$ -23.21M$ -23.88M$ -22.05M$ -21.38M$ -23.98M
Net Income Common Stockholders$ -25.07M$ -24.30M$ -20.34M$ -20.98M$ -24.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 190.27M$ 206.07M$ 123.64M$ 142.88M$ 160.19M
Total Assets$ 230.98M$ 248.69M$ 164.94M$ 184.73M$ 205.14M
Total Debt$ 25.30M$ 25.82M$ 26.27M$ 25.04M$ 25.50M
Net Debt$ -164.97M$ -180.25M$ -97.38M$ -117.85M$ -134.69M
Total Liabilities$ 37.74M$ 37.97M$ 38.46M$ 40.37M$ 40.57M
Stockholders Equity$ 193.25M$ 210.68M$ 126.48M$ 144.36M$ 163.73M
Cash Flow-
Free Cash Flow$ -21.79M$ -25.35M$ -20.91M$ -18.28M$ -28.00M
Operating Cash Flow$ -21.50M$ -25.20M$ -20.82M$ -17.90M$ -27.46M
Investing Cash Flow$ -5.18M$ -38.49M$ 45.30M$ -24.64M$ -48.23M
Financing Cash Flow$ 5.00M$ 107.24M$ 505.00K-$ 2.62M
Currency in USD

Solid Biosciences Earnings and Revenue History

Solid Biosciences Debt to Assets

Solid Biosciences Cash Flow

Solid Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis